Enhanced expression of a recombinant malaria candidate vaccine in Escherichia coli by codon optimization.

This study was conducted to compare the expression of three constructs of a multistage candidate vaccine (FALVAC-1) against Plasmodium falciparum in an Escherichia coli system: a synthetic gene with P. falciparum codons, a synthetic gene with optimized E. coli codons, and a synthetic gene with P. falciparum codons co-transformed with a RIG plasmid, which encodes three tRNAs (AG(A/G), ATA, GGA) that recognize rare E. coli codons. The expression of the protein increased at least threefold with codon optimization. The presence of the RIG plasmid in the co-transforming cells did not significantly increase the expression level of the gene with P. falciparum codons. The growth of cells transformed by the construct with P. falciparum codons was significantly slower than that of cells transformed by the construct with optimized E. coli codons after induction of protein expression with IPTG. The cells containing the non-codon optimized gene co-expressed with RIG plasmid had the slowest growth at all time points in culture. Thus, codon optimization significantly increases the yield of P. falciparum candidate vaccines in the E. coli expression system.

[1]  G. W. Hatfield,et al.  Codon Pair Utilization Biases Influence Translational Elongation Step Times (*) , 1995, The Journal of Biological Chemistry.

[2]  A. Lal,et al.  Development, expression, and murine testing of a multistage Plasmodium falciparum malaria vaccine candidate. , 2000, Vaccine.

[3]  C. Ehresmann,et al.  Ribosomal protein S15 from Escherichia coli modulates its own translation by trapping the ribosome on the mRNA initiation loading site. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[4]  U. Brinkmann,et al.  High-level expression of recombinant genes in Escherichia coli is dependent on the availability of the dnaY gene product. , 1989, Gene.

[5]  C. Kurland,et al.  Errors of heterologous protein expression. , 1996, Current opinion in biotechnology.

[6]  S. Hoffman,et al.  Immunogenicity and in vitro protective efficacy of a recombinant multistage Plasmodium falciparum candidate vaccine. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[7]  C. Kurland,et al.  Bacterial growth inhibition by overproduction of protein , 1996, Molecular microbiology.

[8]  W. Fiers,et al.  Preferential codon usage in prokaryotic genes: the optimal codon-anticodon interaction energy and the selective codon usage in efficiently expressed genes. , 1982, Gene.

[9]  Toshimichi Ikemura,et al.  Condon usage tabulated from the international DNA sequence databases , 1996, Nucleic Acids Res..

[10]  M. Klinkert,et al.  Identification and biochemical characterisation of a protein phosphatase 5 homologue from Plasmodium falciparum. , 2002, Molecular and biochemical parasitology.

[11]  A. Villaverde,et al.  Connection between gene dosage and protein stability revealed by a high-yield production of recombinant proteins in an E. coli LexA1(Ind-) background. , 2002, Biotechnology and bioengineering.

[12]  P. Sharp,et al.  The codon Adaptation Index--a measure of directional synonymous codon usage bias, and its potential applications. , 1987, Nucleic acids research.

[13]  G. W. Hatfield,et al.  Nonrandom utilization of codon pairs in Escherichia coli. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[14]  T. Horii,et al.  Production of recombinant SERA proteins of Plasmodium falciparum in Escherichia coli by using synthetic genes. , 1996, Vaccine.

[15]  P. Prapunwattana,et al.  Chemical synthesis of the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene. , 1996, Molecular and biochemical parasitology.

[16]  T. Horii,et al.  Purification and characterization of dihydrofolate reductase of Plasmodium falciparum expressed by a synthetic gene in Escherichia coli. , 1994, Molecular and biochemical parasitology.

[17]  M. Inouye,et al.  Suppression of the negative effect of minor arginine codons on gene expression; preferential usage of minor codons within the first 25 codons of the Escherichia coli genes. , 1990, Nucleic acids research.

[18]  M. Grainger,et al.  PCR-based gene synthesis as an efficient approach for expression of the A+T-rich malaria genome. , 1999, Protein engineering.

[19]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[20]  J. Kane,et al.  Effects of rare codon clusters on high-level expression of heterologous proteins in Escherichia coli. , 1995, Current opinion in biotechnology.

[21]  J. Craig Venter,et al.  Plasmodium, human and Anopheles genomics and malaria , 2002, Nature.

[22]  C. Kensil,et al.  Influence of adjuvants in inducing immune responses to different epitopes included in a multiepitope, multivalent, multistage Plasmodium falciparum candidate vaccine (FALVAC-1) in outbred mice. , 2002, Experimental parasitology.

[23]  T. Ikemura.  Correlation between the abundance of Escherichia coli transfer RNAs and the occurrence of the respective codons in its protein genes: a proposal for a synonymous codon choice that is optimal for the E. coli translational system. , 1981, Journal of molecular biology.

[24]  David W. E. Smith.  Problems of Translating Heterologous Genes in Expression Systems: The Role of tRNA , 1996, Biotechnology progress.

[25]  R. Christopherson,et al.  A hybrid plasmid for expression of toxic malarial proteins in Escherichia coli. , 2001, Molecular and biochemical parasitology.

[26]  C. Kurland,et al.  Gratuitous overexpression of genes in Escherichia coli leads to growth inhibition and ribosome destruction , 1995, Journal of bacteriology.

[27]  E. Paoletti,et al.  NYVAC-Pf7: a poxvirus-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria , 1996, Infection and immunity.

[28]  F. Studier,et al.  Consecutive low-usage leucine codons block translation only when near the 5' end of a message in Escherichia coli. , 1995, Journal of molecular biology.

[29]  E. Goldman,et al.  Low-usage codons in Escherichia coli, yeast, fruit fly and primates. , 1991, Gene.

[30]  G. Hui,et al.  An experimental vaccine cocktail for Plasmodium falciparum malaria. , 1993, Vaccine.

[31]  L. Isaksson,et al.  Codon choice and potential complementarity between mRNA downstream of the initiation codon and bases 1471-1480 in 16S ribosomal RNA affects expression of glnS. , 1991, Nucleic acids research.

[32]  D. Battistutta,et al.  Codon usage in Plasmodium falciparum. , 1988, Molecular and biochemical parasitology.

[33]  R. Sauer,et al.  SsrA‐mediated peptide tagging caused by rare codons and tRNA scarcity , 1999, The EMBO journal.

[34]  W G Hol,et al.  International Journal for Parasitology 30 (2000) 113±118 Rapid communication , 2000 .

[35]  M. Inouye,et al.  Role of the AGA/AGG codons, the rarest codons in global gene expression in Escherichia coli. , 1994, Genes & development.

[36]  P. Fallon,et al.  AGA/AGG codon usage in parasites: implications for gene expression in Escherichia coli. , 1995, Parasitology today.

[37]  H. Bujard,et al.  Vaccine candidate MSP-1 from Plasmodium falciparum: a redesigned 4917 bp polynucleotide enables synthesis and isolation of full-length protein from Escherichia coli and mammalian cells. , 1999, Nucleic acids research.

[38]  F. Studier,et al.  Effects of consecutive AGG codons on translation in Escherichia coli, demonstrated with a versatile codon test system , 1993, Journal of bacteriology.

[39]  D. Lawrence.  Combination malaria vaccine shows early promise in human trials , 2003, The Lancet.

[40]  G. Hannig,et al.  Strategies for optimizing heterologous protein expression in Escherichia coli. , 1998, Trends in biotechnology.

[41]  K. Zahn,et al.  Overexpression of an mRNA dependent on rare codons inhibits protein synthesis and cell growth , 1996, Journal of bacteriology.